HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chiung-Chi Peng Selected Research

imidazole mustard (BIC)

4/2022Bicalutamide may enhance kidney injury in diabetes by concomitantly damaging energy production from OXPHOS and glycolysis.
12/2021Bicalutamide Exhibits Potential to Damage Kidney via Destroying Complex I and Affecting Mitochondrial Dynamics.
5/2020Bicalutamide Elicits Renal Damage by Causing Mitochondrial Dysfunction via ROS Damage and Upregulation of HIF-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chiung-Chi Peng Research Topics

Disease

8Chronic Renal Insufficiency
06/2020 - 06/2012
7Prostatic Neoplasms (Prostate Cancer)
04/2022 - 05/2004
4Hypoxia (Hypoxemia)
04/2022 - 03/2013
4Hypertension (High Blood Pressure)
04/2020 - 10/2012
4Body Weight (Weight, Body)
11/2015 - 01/2013
3Mitochondrial Diseases (Mitochondrial Disease)
04/2022 - 05/2020
3Fibrosis (Cirrhosis)
04/2022 - 03/2019
3Inflammation (Inflammations)
11/2015 - 01/2013
3Hemorrhage
02/2015 - 03/2013
3Hyperplasia
02/2015 - 05/2004
3Teratogenesis
01/2015 - 01/2012
2Type 2 Diabetes Mellitus (MODY)
01/2019 - 10/2009
2Coronary Artery Disease (Coronary Atherosclerosis)
12/2016 - 10/2005
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
11/2015 - 01/2013
2Muscular Diseases (Myopathy)
02/2015 - 01/2014
2Neural Tube Defects (Exencephaly)
03/2014 - 01/2013
2Amyloidosis
07/2013 - 10/2012
1Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy)
12/2021
1Acute Kidney Injury (Acute Renal Failure)
12/2021
1Malnutrition (Nutritional Deficiencies)
03/2021
1Neuroblastoma
06/2019
1Obesity
03/2019
1Kidney Diseases (Kidney Disease)
03/2019
1Renal Insufficiency (Renal Failure)
03/2019
1Weight Loss (Weight Reduction)
01/2019
1Dyslipidemias (Dyslipidemia)
03/2018
1Uremia
10/2017
1Hypercholesterolemia
12/2016
1Myocardial Infarction
12/2016
1Diabetes Mellitus
11/2015
1Cerebral Hemorrhage
02/2015
1Hemolysis
01/2015
1Reperfusion Injury
12/2014

Drug/Important Bio-Agent (IBA)

6AndrogensIBA
04/2022 - 01/2007
4CollagenIBA
11/2015 - 10/2012
4Triglycerides (Triacylglycerol)IBA
03/2014 - 10/2005
3bicalutamide (Casodex)FDA LinkGeneric
04/2022 - 05/2020
3imidazole mustard (BIC)IBA
04/2022 - 05/2020
3Interleukin-6 (Interleukin 6)IBA
11/2015 - 01/2011
3Malondialdehyde (Propanedial)IBA
02/2015 - 10/2012
3CholesterolIBA
02/2015 - 10/2012
3Gallic AcidIBA
02/2015 - 06/2012
3Valproic Acid (Depakote)FDA LinkGeneric
01/2015 - 01/2012
3Doxorubicin (Adriamycin)FDA LinkGeneric
07/2013 - 10/2012
3QuercetinIBA
07/2013 - 08/2010
3Insulin (Novolin)FDA Link
10/2012 - 10/2009
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2021 - 01/2015
2LipidsIBA
06/2020 - 03/2019
2CreatinineIBA
03/2018 - 10/2012
2Carnitine (L-Carnitine)FDA LinkGeneric
02/2015 - 03/2014
2Superoxide DismutaseIBA
02/2015 - 10/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2015 - 01/2011
2Urea (Carbamide)FDA LinkGeneric
07/2013 - 10/2012
2NitrogenIBA
07/2013 - 10/2012
2Estrogens (Estrogen)FDA Link
01/2013 - 10/2005
2Therapeutic UsesIBA
10/2012 - 06/2012
2Caspase 3 (Caspase-3)IBA
10/2012 - 01/2007
2ferulic acid (sodium ferulate)IBA
06/2012 - 08/2010
2Pharmaceutical PreparationsIBA
01/2012 - 01/2012
2Matrix Metalloproteinases (MMPs)IBA
01/2011 - 01/2007
2SecretagoguesIBA
08/2010 - 10/2009
2Complex MixturesIBA
01/2007 - 01/2007
1protein kinase PIBA
04/2022
1Adenosine Triphosphate (ATP)IBA
04/2022
1SirtuinsIBA
12/2021
1NADPH Oxidase 4IBA
12/2021
1Proteins (Proteins, Gene)FDA Link
03/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
06/2020
1Acetyl-CoA CarboxylaseIBA
06/2020
1Fatty Acid Synthases (Fatty Acid Synthase)IBA
06/2020
1Messenger RNA (mRNA)IBA
05/2020
1Fluoxetine (Prozac)FDA LinkGeneric
06/2019
1geniposideIBA
06/2019
1IridoidsIBA
06/2019
1Biomarkers (Surrogate Marker)IBA
03/2019
1BilirubinIBA
10/2017
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2017
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2017
1Angiotensin Receptor AntagonistsIBA
01/2017
1Antihypertensive Agents (Antihypertensives)IBA
01/2017
1Blood Glucose (Blood Sugar)IBA
11/2015
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
11/2015
1Androgen Receptors (Androgen Receptor)IBA
11/2015
1Dihydrotestosterone (Androstanolone)IBA
11/2015
1Testosterone (Sustanon)FDA Link
11/2015
1Thiobarbituric Acid Reactive SubstancesIBA
11/2015
1Insulin-Like PeptidesIBA
11/2015
1Hypolipidemic Agents (Antihyperlipidemics)IBA
05/2015
1GlucansIBA
02/2015
1Creatine Kinase (Creatine Phosphokinase)IBA
02/2015
1Interleukin-1 (Interleukin 1)IBA
02/2015
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
02/2015
1oxidized low density lipoproteinIBA
02/2015
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
02/2015
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
01/2015
1TeaIBA
01/2015

Therapy/Procedure

7Therapeutics
04/2022 - 10/2005
2Renal Dialysis (Hemodialysis)
10/2017 - 12/2016
1Bariatric Surgery
01/2019
1Peritoneal Dialysis
03/2018